STAT
JUNE 30, 2025
American medical research is a unique source of national pride and reputation — some would say the United States’ most important export. Yet Secretary of Health and Human Services Robert F. Kennedy Jr. seems bent on destroying our greatest successes. As the latest strike, Kennedy is going after the publications that disseminate medical research.
Beckers Hospital Review
JUNE 30, 2025
Kansas City, Mo.-based St. Luke’s Health System has launched outbound pharmacy delivery from its new Consolidated Service Center, centralizing medication distribution to 14 acute care and St. Luke’s Cancer Institute pharmacy locations as of June 19. The rollout marks the first phase of a broader shift toward a more integrated pharmacy operation, according to a June 27 LinkedIn post from Kelley Curtis, PharmD, vice president and chief pharmacy officer at St.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JUNE 30, 2025
A new blood test could predict preeclampsia as early as the first trimester. In a new study, researchers successfully predicted the early-onset subtype of the prenatal condition up to five months before clinical diagnosis. The findings are being presented Monday during the annual meeting of the European Society of Human Reproduction and Embryology, in Paris.
FDA Law Blog: Biosimilars
JUNE 30, 2025
By Larry K. Houck — A memorable Florida Orange Growers’ television ad campaign in the late 1970s proclaimed that “Orange juice from Florida isn’t just for breakfast anymore.” The Federal Controlled Substances Act (“CSA”) and its regulations require Drug Enforcement Administration (“DEA”) registrants to submit certain reports related to narcotic drug transactions, thefts and significant losses, and suspicious orders.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
STAT
JUNE 30, 2025
Reducing inflammation has become all the rage lately, with many medical experts pointing to anti-inflammatory diets and other lifestyle changes as ways people can reduce their risk of chronic disease as they age. But a new study suggests that inflammation’s effects on health are more complex than scientists previously understood. In a study published in Nature Aging on Monday, researchers found that people living in non-industrialized societies experience less age-related chronic in
Pharmacy Times
JUNE 30, 2025
Christopher Danes, PhD, discusses how discrete choice experiment data reveal key differences in patient and caregiver treatment preferences for ALK-positive (ALK+) non–small cell lung cancer (NSCLC) and how pharmacists can use these insights to guide shared decision-making, optimize supportive care, and personalize adherence strategies.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharmacy Times
JUNE 30, 2025
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to
STAT
JUNE 30, 2025
AbbVie said Monday that it would pay up to $2.1 billion to acquire Capstan Therapeutics , a startup developing CAR-T therapies for autoimmune conditions, fibrosis, and cancer. AbbVie will pay up to $2.1 billion in cash when the deal closes, according to a press release. The companies did not give further details about the financial terms or a timeline for completing the acquisition.
Pharmacy Times
JUNE 30, 2025
Gianni Scappaticci, PharmD, BCOP, discusses key considerations in therapy selection, limitations of current treatments, and the evolving role of pharmacists in managing chronic graft-versus-host disease (cGVHD) through patient education, adherence support, and integration of emerging therapies.
Big Molecule Watch
JUNE 30, 2025
On June 25, 2025, Kashiv BioSciences announced positive topline results from its confirmatory Phase 3 trial of ADL-018, a proposed biosimilar to XOLAIR® (omalizumab), in patients with chronic spontaneous urticaria. The study met both primary and secondary endpoints, demonstrating therapeutic equivalence and comparable safety to the reference product.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The Pharmacist
JUNE 30, 2025
Almost three-quarters (74%) of pharmacy owners in England have said their business is spending ‘longer than ever before’ to procure medicines amid worsening supply issues, a survey has revealed. Community Pharmacy England’s 2025 annual pressures survey has added weight to ongoing concerns over medicines supply challenges and the impact this is having on both the […] The post Pharmacies spending ‘longer than ever’ managing medicines supply issues appeared first on The Pharmacist.
Pharma Times
JUNE 30, 2025
Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs Cidara and hVIVO report positive results in flu prevention study by John Pinching | 30th Jun 2025 | News New data show strong efficacy of CD388 in phase 2b trial Cidara Therapeutics and hVIVO have announced encouraging topline results from a global phase 2b field study evaluating CD388, a drug-Fc conjuga
Pharmacy Times
JUNE 30, 2025
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to
pharmaphorum
JUNE 30, 2025
There is enough experience with the first wave of autologous CAR-T therapies to allow strict rules ensuring their safe use to be relaxed, says FDA.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Pharmacy Times
JUNE 30, 2025
Gayathri Namasivayam, PhD, discusses how large language models are being used to extract structured oncology data from unstructured electronic health records to improve clinical efficiency, support real-world evidence generation, and enhance oncology pharmacy workflows.
Express Pharma
JUNE 30, 2025
The global life sciences map is being redrawn. Forget the sole dominance of Boston, Cambridge, and the Bay Area. A new force is emerging from India: Hyderabad. This isn’t just another manufacturing hub; it’s an ecosystem integrating scientific research with production capabilities. For leaders navigating the future of healthcare and biotech, understanding Hyderabad’s ascent is no longer optional – it’s a strategic imperative.
Pharmacy Times
JUNE 30, 2025
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to
Pharma Times
JUNE 30, 2025
Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs UCB reports success in phase 3 study of fenfluramine for CDD by John Pinching | 30th Jun 2025 | News Positive trial results offer hope for those with ultra-rare epileptic disorder UCB has announced that its phase 3 trial evaluating fenfluramine in CDKL5 deficiency disorder (CDD) achieved its primary and
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Pharmacy Times
JUNE 30, 2025
An expert discusses how pharmacists can identify high-risk patients for pneumococcal disease by reviewing medication profiles for immunosuppressants and using electronic medical record vaccine tracking tools, while emphasizing that vulnerable populations face higher morbidity, mortality, and hospitalization rates compared with healthy individuals.
Beckers Hospital Review
JUNE 30, 2025
The Justice Department, through its 2025 National Health Care Fraud Takedown investigation, has charged 324 defendants in schemes involving more than $14.6 billion in intended losses to Medicare, Medicaid and other government programs. Five things to know: 1. The 2025 operation was the largest in the department’s history, more than double the previous record of $6 billion, according to a June 30 department news release. 2.
Express Pharma
JUNE 30, 2025
Alembic Pharmaceuticals announced that it has received final approval from the United States Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Doxorubicin Hydrochloride Liposome Injection. The approval includes 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) single-dose vials. The product is therapeutically equivalent to the reference listed drug (RLD), Doxil Liposome Injection, in the same strengths, marketed by Baxter Healthcare Corporation.
STAT
JUNE 30, 2025
ASPEN, Colo. — When Jessica Owens was toiling away in graduate school, she didn’t know what a venture capitalist was, much less that she’d one day launch her own firm and raise its inaugural $45 million fund. Owens co-founded Initiate Ventures, a Bay Area VC firm, after a winding career that spans roles at the Centers for Disease Control and Prevention and a stint in a cancer biology Ph.D. program before she ditched the lab to explore the world of finance.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Pharmaceutical Business Review
JUNE 30, 2025
This agreement grants Qilu exclusive rights to develop, manufacture, enhance, utilise and commercialise Albipagrastim alfa for Injection in Greater China including Chinese Mainland, Macau, Hong Kong and Taiwan. T-mab will potentially receive up to 500m yuan ($69m) upfront payment and sales milestones, along with royalties on net sales. Albipagrastim alfa is a recombinant human serum albumin (HAS) or human granulocyte-colony stimulating factor (I) (G-CSF) fusion protein.
pharmaphorum
JUNE 30, 2025
With tariffs looming, Indian drugmaker Hikma has said it will spend $1bn to expand its manufacturing and R&D operations in the US by 2030.
STAT
JUNE 30, 2025
WASHINGTON — The Department of Health and Human Services will renew funding to states for cancer prevention and tracking efforts, alleviating anxieties among local officials about the future of their work. Over 50 notices had gone out as of Monday, an HHS spokesperson said. The rest of the awards will be sent to states, tribes, and other contractors “no later than early next week,” press secretary Emily Hilliard told STAT in an email.
World Pharma News
JUNE 30, 2025
A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines. Type 2 diabetes (T2D), a condition in which the body can't use insulin to clear sugar from the bloodstream, affects 1 in 10 Americans. It comes with grave health risks, including cardiovascular and kidney disease.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
JUNE 30, 2025
The Trump administration recently canceled $766 million in contracts with Moderna to develop and produce an mRNA vaccine against pandemic influenza viruses, including H5N1 avian flu. This is a tragic decision for many reasons, and also quite ironic. Perhaps the most important thing President Trump did during his first term was to invest in Operation Warp Speed, which gave us mRNA-based Covid-19 vaccines in time to save millions of lives here and around the world.
Pharmafile
JUNE 30, 2025
The US Food and Drug Administration (FDA) has approved Gamifant (emapalumab-lzsg) for the treatment of macrophage activation syndrome (MAS) in adult and paediatric patients with known or suspected Still’s disease, including systemic juvenile idiopathic arthritis. Announced by biopharma company Sobi, the approval makes Gamifant the first-ever FDA-approved therapy for MAS.
Express Pharma
JUNE 30, 2025
The Institute of Chemical Technology (ICT), Mumbai, announces the selection of Dr Prajakta Dandekar Jain, UGC Assistant Professor, Department of Pharmaceutical Sciences and Technology, as a Founding Member of the newly constituted INSA Women Associates (IWA) by the Indian National Science Academy (INSA), New Delhi. This recognition celebrates Dr. Jain’s contributions in the field of pharmaceutical biotechnology and her unwavering commitment to mentorship, interdisciplinary collaboration, and ad
Beckers Hospital Review
JUNE 30, 2025
The FDA has eliminated Risk Evaluation and Mitigation Strategies for all currently approved BCMA- and CD19-directed autologous CAR-T cell immunotherapies, determining that the safety program is no longer necessary to ensure the benefits of the therapies outweigh the risks. The FDA said existing clinical experience and improved understanding of managing severe side effects, such as cytokine release syndrome and neurologic toxicities, mean the products can be safely administered without the REMS r
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Expert insights. Personalized for you.
364 
Let's personalize your content